title: Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre.
abstract: OBJECTIVE
  Alcohol and the hepatitis C virus have been postulated to interact to adversely affect the natural history of patients with chronic liver disease. The aim of this study was to examine the effect of alcohol on hepatitic activity and serum HCV RNA levels in patients with chronic hepatitis C.
  
  
  METHODS
  Forty-five consecutive patients with chronic hepatitis C were classified according to alcohol intake over the 3-month period preceding study entry: group 1 (n = 23), > 10 g alcohol/day; group 2 (n = 22), < or = 10 g alcohol/day. Hepatitic activity and alcohol intake were assessed at study entry and, following moderation of alcohol intake, after a mean follow-up period of 4.4 +/- 0.2 months.
  
  
  RESULTS
  Hepatitic activity was significantly greater in the patients who consumed > 10 g of alcohol/day. Moderation of alcohol consumption in patients consuming > 10 g/day resulted in a significant decrease in both disease activity (p = 0.0002) and viral RNA titre (p = 0.018); there was no change over the study period in patients with a consistently low alcohol intake.
  
  
  CONCLUSIONS
  The results support the hypotheses that, in patients with chronic hepatitis C, alcohol aggravates hepatic injury, increases viral load and adversely affects the natural history of the associated liver disease.
authors.affiliation: Gastroenterology Department, Alfred Hospital, Melbourne, Australia.
authors.forename: S L
authors.initials: SL
authors.lastname: Cromie
authors.forename: P J
authors.initials: PJ
authors.lastname: Jenkins
authors.forename: D S
authors.initials: DS
authors.lastname: Bowden
authors.forename: F J
authors.initials: FJ
authors.lastname: Dudley
mesh_terms: D000410:Alanine Transaminase / Q000097:blood / Q000187:drug effects; D000428:Alcohol Drinking / Q000097:blood* / Q000473:pathology; D001219:Aspartate Aminotransferases / Q000097:blood / Q000187:drug effects; D015415:Biomarkers / Q000097:blood; D001706:Biopsy; D002908:Chronic Disease; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics*; D006526:Hepatitis C / Q000097:blood* / Q000473:pathology / Q000821:virology; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood*; D000637:Transaminases / Q000097:blood / Q000187:drug effects; D005723:gamma-Glutamyltransferase / Q000097:blood / Q000187:drug effects
chemical_list: D015415:Biomarkers; D012367:RNA, Viral; D005723:gamma-Glutamyltransferase; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase